von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker) Antibody - With BSA and Azide
Mouse Monoclonal Antibody [Clone IIIE2.34 ]
- 产品详情
- 实验流程
- 背景知识
Application ![]()
| WB, IHC, IF, FC, IP |
---|---|
Primary Accession | P04275 |
Other Accession | 7450, 440848 |
Reactivity | Human |
Host | Mouse |
Clonality | Monoclonal |
Isotype | Mouse / IgG1, kappa |
Clone Names | IIIE2.34 |
Calculated MW | 309265 Da |
Gene ID | 7450 |
---|---|
Other Names | von Willebrand factor, vWF, von Willebrand antigen 2, von Willebrand antigen II, VWF, F8VWF |
Application Note | WB~~1:1000 IHC~~1:100~500 IF~~1:50~200 FC~~1:10~50 IP~~N/A |
Storage | Store at 2 to 8°C.Antibody is stable for 24 months. |
Precautions | von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker) Antibody - With BSA and Azide is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | VWF |
---|---|
Synonyms | F8VWF |
Function | Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet- surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma. |
Cellular Location | Secreted. Secreted, extracellular space, extracellular matrix. Note=Localized to storage granules |
Tissue Location | Plasma. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi’s sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.
REFERENCES
Motta, A. et al. 2009. J Biomater Sci Polym Ed. 20: 1875-1897. | Germann, B. et al. 2008. Pharmazie. 63: 303-307

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.